This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd., Centaurus Biopharma Co., Ltd.. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Xianxing Shang: Innovator in Pharmaceutical Chemistry
Introduction
Xianxing Shang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific protein activities.
Latest Patents
Xianxing Shang holds two patents that showcase his innovative work. The first patent involves an iminosulfanone compound that acts as a bromodomain protein inhibitor. This invention includes a preparation method, pharmaceutical composition, and medical applications. The second patent focuses on a compound represented by a specific formula that serves as an inhibitor of epidermal growth factor receptor (EGFR) activity. This disclosure relates to aniline pyrimidine derivatives and their pharmaceutical uses for treating diseases mediated by EGFR.
Career Highlights
Throughout his career, Xianxing Shang has worked with prominent companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Xianxing Shang has collaborated with several professionals in his field, including Yan Zhu and Ling Yang. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.
Conclusion
Xianxing Shang is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in medical treatments. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile